Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Part of paid clinical trials in San Francisco, California.
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Study ID
- NCT00365599
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- suberoylanilide hydroxamic acid (SAHA, Vorinostat) — DRUGVorinostat will be used to potentiate the effects of tamoxifen or overcome tamoxifen resistance. All patients will receive vorinostat at 400 mg by mouth (po) daily for 3 out of 4 weeks. Responses will be assessed after 2 cycles (8 weeks + 4 days).
- tamoxifen citrate (Tamoxifen) — DRUGTamoxifen will be given once daily at 20 mg. Tamoxifen will be given continuously. Responses will be assessed after 2 cycles (8 weeks + 4 days).
Study Details
Phase II trial to explore the efficacy of vorinostat and tamoxifen combined.
Key Dates
- Start date
- Feb 28, 2006
- Status verified
- Nov 2014
- Primary completion
- Apr 30, 2011
- Completion
- Aug 31, 2012
Study Design
- Enrollment
- 43 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Vorinostat and TamoxifenAs outlined in Intervention descriptions
Primary Outcome Measure
Number of Participants With Objective Response (OR) [ Time Frame: 24 weeks ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California | San Francisco | California | 94143 | - |
| Bethesda Memorial Hospital Research Center | Boynton Beach | Florida | 33435 | - |
| M.D. Anderson of Orlando | Orlando | Florida | 32806 | - |
| Fawcett Memorial Hospital | Port Charlotte | Florida | 33949 | - |
| Martin Memorial Cancer Center | Stuart | Florida | 34994 | - |
| Tallahassee Memorial HealthCare, Inc. | Tallahassee | Florida | 32308 | - |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | - |
| St. Joseph's/Candler | Savannah | Georgia | 31405 | - |
Find similar trials in San Francisco, CA
By condition
By specialty
Related Studies
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California
- Magnetic Resonance Imaging of Breast CancerRecruiting · Stanford University · Stanford, California
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona